ABCL Live signals | Maximize Profits with Getagraph.com

SELL 157604 min ago

@ $5.26

Issued: 14 Feb 2024 @ 14:38

Return: -25.40%

Previous signal: Feb 14 - 12:00

Previous signal: Buy

Return: 1.06 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	1.07M
Average Volume	1.28M
Market Cap	1.15B
EPS	$0 ( 2024-05-07 )
Next earnings date	( $-0.160 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.69
ATR14	$0.00800 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-26	Hansen Carl L. G.	Sell	56 125	Share option (right to buy)
2024-02-26	Hansen Carl L. G.	Buy	56 125	Common Shares
2024-01-14	Lecault Veronique	Buy	770 416	Share option (right to buy)
2024-01-14	Stimart Tryn	Buy	616 333	Share option (right to buy)
2024-01-14	Booth Andrew	Buy	770 416	Share option (right to buy)

INSIDER POWER
79.66
Last 95 transactions
Buy: 16 009 839 \| Sell: 26 316 378

Volume Correlation

Long: -0.21 (neutral)

Short: 0.83 (strong)

Signal:(62.416) Same movement expected

AbCellera Biologics Inc. Correlation

10 Most Positive Correlations
OZEM	1
SIRI	0.955
OSUR	0.95
PRTS	0.95
SSYS	0.95
CMTL	0.949
APTO	0.948
ALLR	0.947
DCFC	0.944
APVO	0.944

10 Most Negative Correlations
SWAV	-0.946
IVCB	-0.94
RZLT	-0.936
APXI	-0.934
BOCN	-0.932
CSLM	-0.931
PNTG	-0.931
XFIN	-0.929
ARYD	-0.928
ENTX	-0.928

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AbCellera Biologics Inc. Correlation - Currency/Commodity

0.29
( neutral )

0.16
( neutral )

0.00
( neutral )

0.02
( neutral )

AbCellera Biologics Inc. Financials

Annual	2023
Revenue:	$38.03M
Gross Profit:	$7.13M (18.75 %)
EPS:	$-0.510

FY	2023
Revenue:	$38.03M
Gross Profit:	$7.13M (18.75 %)
EPS:	$-0.510

FY	2022
Revenue:	$485.42M
Gross Profit:	$418.99M (86.31 %)
EPS:	$0.560

FY	2021
Revenue:	$375.20M
Gross Profit:	$329.69M (87.87 %)
EPS:	$0.960

Financial Reports:

No articles found.

AbCellera Biologics Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

AbCellera Biologics Inc.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.